Wednesday, May 29, 2013


Source Article:
The medical textbook definition of a vaccine adverse reaction: Brain Infection (Merck Manual)

"Here is the definition of a vaccine adverse reaction from the largest selling medical textbook, the Merck Manual (see below), filed under their category of brain, spinal cord and nerve disorders: brain infections.

The brain infection caused by vaccines is encephalitis.

Encephalitis is inflammation of the brain. Patients who suffer encephalitis can be left with physical disabilities, mental deterioration and persistent cognitive dysfunction – which matches the definition of autism.

Vaccines can cause encephalitis and encephalitis can cause autism.

Below the following text is a list of ten vaccine package inserts that have the brain infection encephalitis as an adverse reaction.

Below that are medical journal references to vaccine-induced encephalitis and mental deterioration and disability after encephalitis.

At the very bottom of this page are articles describing secret multi-million dollar US government compensation payments to children that suffered vaccine-induced encephalitis and who are now autistic.

The following text is from my chapter of the book Vaccine Epidemic.


‘Vaccines can cause brain damage. Most people are completely unaware of this, but that is exactly how The Merck Manual, the largest-selling medical textbook, defines an adverse reaction to a vaccine: ‘Encephalitis is inflammation of the brain that occurs when a virus directly infects the brain or when a virus or something else triggers inflammation . . . Encephalitis can occur in the following ways: A virus directly infects the brain. A virus that caused an infection in the past becomes reactivated and directly damages the brain. A virus or vaccine triggers a reaction that makes the immune system attack brain tissue (an autoimmune reaction)‘ [emphasis added].

A vaccine adverse reaction that causes brain damage (encephalitis) is the same thing as a complication from an infectious disease. Any pediatrician, doctor, or state or federal public-health official who tells you that vaccines are completely safe, that adverse reactions to vaccines don’t exist, or that vaccine-induced injuries are so rare that they virtually never occur is either ignorant or is committing scientific fraud. Is it worse to have your child vaccinated by a doctor who does not know the possible adverse reactions, or to be lied to by a doctor or government bureaucrat who does know the terrible damage vaccines can cause?

This is no trivial matter. Every day, uninformed physicians administer vaccines to vast numbers of children and adults with little thought about the possibility of adverse reactions. When an adverse reaction occurs—in the form of brain inflammation, convulsions, or another injury—the typical first step is to blame someone else. Doctors and the government accuse parents of child abuse (i.e., shaken baby syndrome) or bad luck (i.e., defective genes) and accuse teenagers of bad behavior (i.e., using illicit drugs). Medical professionals do not step up and ask whether they hold any responsibility for causing an adverse reaction to a vaccine.

The Merck Manual further defines the symptoms of encephalitis: “Symptoms of encephalitis include fever, headache, personality changes or confusion, seizures, paralysis or numbness, sleepiness that can progress to coma and death.”

Many tens of thousands of parents whose children were diagnosed with autism spectrum disorder reported that their kids were progressing normally until they received one or many vaccines, after which they had fevers, headaches, seizures, personality changes, and were never the same again. The symptoms reported by parents are the same symptoms of encephalitis that are defined in The Merck Manual. Health authorities in charge of defending and expanding universal immunization programs label these same symptoms “a coincidence.”’

Vaccine package inserts that list encephalitis as an adverse reaction

Merck M-M-R® II Package Insert (Measles, Mumps, and Rubella Virus Vaccine Live) ADVERSE REACTIONS, Nervous System
Encephalitis; encephalopathy

Merck Hepatitis B Vaccine Package Insert RECOMBIVAX HB®
ADVERSE REACTIONS, Marketed Experience, Nervous System

Merck GARDASIL Package Insert (Human Papillomavirus Quadrivalent) ADVERSE REACTIONS, Postmarketing Experience, Nervous system
Acute disseminated encephalomyelitis

Merck Chickenpox Vaccine Package Insert VARIVAX® Varicella Virus Vaccine Live
ADVERSE REACTIONS, post-marketing

Glaxo Pertussis Vaccine Package Insert INFANRIX (DTaP)
Postmarketing Experience, Nervous System Disorders

DTaP IPV and HIB Combo Vaccine Package Insert PENTACEL Sanofi Pasteur
Data from Clinical Studies, Serious Adverse Events

Flu Mist Vaccine Package Insert MedImmune FLUMIST® (Influenza Vaccine Live, Intranasal Spray)
Postmarketing Experience, Nervous system disorders
Vaccine-associated encephalitis

Flu Vaccine Package Insert AFLURIA – CSL marketed by Merck
Postmarketing Experience, Nervous system disorders

Flu Vaccine Package Insert AGRIFLU – Novartis Vaccines
Postmarketing Experience, Nervous system disorders
Encephalomyelitis and transverse myelitis

Flu Vaccine Package Insert FLUARIX GlaxoSmithKline
Postmarketing Experience, Nervous system disorders


Medical journal and textbook articles about vaccines causing encephalitis

Journal of Clinical Neuroscience Volume 15, Issue 12, December 2008

Post-vaccination encephalomyelitis: Literature review and illustrative case


Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disease of the central nervous system that is usually considered a monophasic disease. ADEM forms one of several categories of primary inflammatory demyelinating disorders of the central nervous system including multiple sclerosis, optic neuropathy, acute transverse myelitis, and neuromyelitis optica (Devic’s disease). Post-infectious and post-immunisation encephalomyelitis make up about three-quarters of cases, where the timing of a febrile event is associated with the onset of neurological disease. Post-vaccination ADEM has been associated with several vaccines such as rabies, diphtheria–tetanus–polio, smallpox, measles, mumps, rubella, Japanese B encephalitis, pertussis, influenza, hepatitis B, and the Hog vaccine. We review ADEM with particular emphasis on vaccination as the precipitating factor.


Neuroimmunology in Clinical Practice By Bernadette Kalman, Thomas H. Brannagan Page 89

Acute disseminated encephalomyelitis (ADEM)

What might be termed “typical ADEM” is an acute monophasic, multifocal CNS disturbance arising in the wake of an exogenous stimulus (e.g. febrile illness or vaccination). It is chiefly encountered in prepubertal children, although it may occur in adults. Strictly speaking, it is a pathologically defined entity, consisting of inflamatory perivenular demyelination with relative sparing of axons. Nonetheless, as is the case with MS, it is a disease that affects both white matter and gray matter.


Journal of Neurology Neurosurgery & Psychiatry 2004


ADEM is an inflammatory demyelinating disorder of the central nervous system that is usually monophasic, but a relapsing variant distinct from MS—multiphasic disseminated encephalomyelitis (MDEM) is well-described. ADEM is predominantly, though by no means exclusively, a disease of children and in particular infants. Historically it includes post-infectious encephalomyelitis and post-vaccination encephalomyelitis. While these two syndromes were distinguished by their precipitant it was realised that clinically and pathologically they were very similar.


Nature Reviews Immunology 7, 904-912 (November 2007)

The origin and application of experimental autoimmune encephalomyelitis

Experimental autoimmune encephalomyelitis (EAE) is a model of the neuroimmune system responding to priming with central nervous system (CNS)-restricted antigens. It is an excellent model of post-vaccinal encephalitis and a useful model of many aspects of multiple sclerosis. EAE has been established in numerous species and is induced by priming with a large number of CNS-derived antigens


National Academy of Sciences December 1, 1985 vol. 82 no. 24

Pertussis toxin is required for pertussis vaccine encephalopathy


A mouse model for encephalopathy induced by pertussis immunization has been described; it has features that closely resemble some of the severe reactions, including seizures and a shock-like state leading to death, occasionally seen after administration of Bordetella pertussis (whooping cough) vaccine. Susceptibility to encephalopathy maps to genes of the major histocompatibility complex and correlates as well with the genetic regulation of the level of antibody response to bovine serum albumin. In this study we have investigated which bacterial determinant is responsible for the encephalopathy. Two lines of evidence implicate pertussis toxin as the active bacterial component. Single-site mutants of B. pertussis with single affected virulence factors were tested. A mutant that produces a defective pertussis toxin had greatly diminished capacity to induce encephalopathy, whereas a hemolysin- and adenylate-cyclase-deficient avirulent mutant had the same activity in the mouse model as a virulent strain. Purified pertussis toxin plus bovine serum albumin was tested and found to induce the lethal encephalopathy, demonstrating that the toxin was the critical constituent of B. pertussis responsible for encephalopathy.


Medical journal articles about encephalitis causing mental damage

Pediatric Neurology Volume 29, Issue 2, August 2003

Neurocognitive outcome after acute disseminated encephalomyelitis

Cognitive dysfunction has been demonstrated in multiple sclerosis but has not been extensively studied after acute disseminated encephalomyelitis (ADEM). Because ADEM often presents with widespread demyelination, which may not completely resolve, these patients may be at risk for persistent cognitive dysfunction. The study objective was to explore the profile and severity of neurocognitive sequelae in pediatric ADEM. Children aged 6-15 years diagnosed with ADEM were invited to participate in a structured neurologic assessment, neuropsychological evaluation, and a follow-up magnetic resonance imaging. Nine of 15 children diagnosed with ADEM met the age criteria and six participated in the study. The mean age at presentation was 7.7 years; the mean duration of follow-up was 3.5 years. As a group, these children with prior ADEM performed within the average range on cognitive testing. However, a variety of mild cognitive deficits were demonstrated in each of the children, even in those whose magnetic resonance imaging studies had completely normalized. Four children demonstrated a cognitive profile of relatively poorer visuospatial/visuomotor function. The cognitive deficits observed in these children are similar but less severe than those previously reported in adults and children with multiple sclerosis, which may reflect the monophasic nature of ADEM, compared with the chronic, recurrent demyelination characteristic of multiple sclerosis.


Proceedings of the Royal Society of Medicine 1928 June

Post-Encephalitis and Its Problems

From the after-histories of some 3,000 patients in London, Glasgow, Belfast, Manchester, Bristol, Sheffield and other large towns, it appears that about 40 per cent of notified patients become disabled. Generally speaking, severe sequels are preceded by severe symptoms in the original attack, but the Parkinsonian syndrome is a noteworthy exception to this rule.

Broadly classifying the sufferers from post-encephalitis, rather than the sequelæ observed in this condition, the author discusses (a) those who suffer mainly from physical sequels; (b) those who chiefly show origin of mental deterioration; (c) those who exhibit demoralizations.

The provision of suitable institutional accommodation for those with progressive physical disabilities (often combined with mental failing), the general re-training and education of the youngest victims and the training and control of adolescents with serious character-changes, constitute some of the problems of post-encephalitis.


Pediatric Neurology Volume 37, Issue 2, August 2007

Children and Encephalitis Lethargica: A Historical Review

Between 1917 and the late 1920s, encephalitis lethargica was an epidemic and often lethal neurologic disease. In adults, it typically elicited severe somatic effects, and in particular, various forms of cranial nerve and motor dysfunction. In children, the psychiatric effects were often as severe as the physical consequences. Approximately one third of affected children underwent a rapid transformation from normal behavior to delinquency, often leading to institutionalization. Many neurologic and psychological theories were advanced to explain these severe behavioral changes, and the therapeutic approaches employed ranged from training in dedicated schools to frontal leucotomy.


Articles exposing US Government compensation payments to children with vaccine-induced encephalopathy and autism

Vaccine Court Awards Millions to Two Children With Autism Huffington Post Jan 14, 2013

In the first case, involving a 10-year-old boy from Northern California named Ryan Mojabi, the parents allege that “all the vaccinations” received from 2003-2005, and “more specifically, measles-mumps-rubella (MMR) vaccinations,” caused a “severe and debilitating injury to his brain, described as Autism Spectrum Disorder (‘ASD’).” The parents, who did not want to be interviewed, specifically asserted that Ryan “suffered a Vaccine Table Injury, namely, an encephalopathy” as a result of his MMR vaccination on December 19, 2003.” … In 2009, Ryan’s case was transferred to vaccine court’s Autism Omnibus Proceedings, according to the docket. A year-and-a-half later, the government conceded that MMR vaccine had indeed caused Ryan’s encephalopathy. HHS agreed that “Ryan suffered a Table injury under the Vaccine Act — namely, an encephalitis within five to fifteen days following receipt,” of MMR, records show. “This case is appropriate for compensation.” … A lump sum of $969,474.91, to cover “lost future earnings ($648,132.74), pain and suffering ($202,040.17), and life care expenses for Year One ($119,302.00),” plus $20,000 for past expenses. Another undisclosed sum, several millions more, will be invested in annuities to cover yearly costs for life, which could total $10 million or more, not accounting for inflation.

The second case involves a girl named Emily, whose mother, Jillian Moller, filed back in 2003 and has been fighting in vaccine court since … Emily’s medical record is filled with damage and suffering. One neurologist, for example, noted that Emily “had staring spells and an abnormal EEG.” Another diagnosed “encephalopathy characterized by speech delay and probable global developmental delay that occurred in the setting of temporal association with immunizations as an acute encephalopathy.” Moller filed for an encephalopathy Table injury in 2003, unaware her daughter would be diagnosed with ASD [Autism Spectrum Disorder] … “I don’t understand why they fought so hard,” Moller said. “We had the evidence: the EEG, the MRI, everything was consistent with encephalopathy, post-vaccination. How can government attorneys claim what our doctors said happened, didn’t happen?” … Emily was awarded a lump sum of $1,030,314.22 “for lost future earnings ($739,989.57), pain and suffering ($170,499.77) and life care expenses for Year One ($119,874.88) plus $190,165.40 for past expenses.” … Based on the first year payout, another estimated $9 million will buy annuities for annual expenses through life, which after inflation has the potential to pay over $50 million dollars.


A study entitled Unanswered Questions from the Vaccine Injury Compensation Program: A Review of Compensated Cases of Vaccine-Induced Brain Injury found the National Vaccine Injury Compensation Program (NVICP) acknowledged 83 cases of vaccine-induced brain damage that include autism. [2] Many of these cases include encephalitis, or swelling of the brain.

Unanswered Questions from the Vaccine Injury Compensation Program: A Review of Compensated Cases of Vaccine-Induced Brain Injury
Pace Environmental Law Review May 10, 2011

This preliminary study suggests that the Vaccine Injury Compensation Program [VICP] has been compensating cases of vaccine-induced encephalopathy and residual seizure disorder associated with autism since the inception of the program. Through this preliminary study, the authors have found eighty-three cases of autism among those compensated for vaccine-induced brain damage."